Progressive Ratio Task reveals effectiveness of single-dose psilocybin

Transpharmation shares yet more exciting new data from recent psychedelic focussed studies. Research that clearly demonstrates the Progressive Ratio Task as a powerful tool to assess acute and long-term changes induced by psychedelics in a translationally relevant behavioural measure of depression has been revealed via a newsletter to their subscribers.  

You can find more detail here: or contact us to discuss the study in more detail: Contact us. At Transpharmation, we carry out sponsored preclinical translational in vivo pharmacology research into cannabidiol (CBD), ketamine, psilocybin, DMT, LSD and other psychedelics, for the treatment of neuropsychiatric disorders, providing the necessary data to propel compounds into the clinic.